Related Experiment Videos
Ultrastructure of glomerular basement membrane in active heymann nephritis rats revealed by tissue-negative staining
Y Hayashi1, K Hironaka, K Shikata
1Department of Medicine III, Okayama University Medical School, Okayama, Japan. shikata@ibm.net
Abstract:
Recently, we have developed a tissue-negative staining method, and successfully visualized fine meshwork structure of the glomerular basement membrane (GBM). To clarify the mechanism of proteinuria in active Heymann nephritis, we performed tissue-negative staining and investigated the ultrastructural alterations of the GBM. Active Heymann nephritis, the animal model of human membranous nephropathy, was induced in Lewis rats by the injection of proximal tubular brush border antigen, i.e. Fx1A. Urinary protein excretion was measured and histological studies were performed over 15 weeks following the Fx1A injection. Proteinuria developed at 10 weeks after injection (38.2 +/- 7.4 mg/day) and progressively increased (160.2 +/- 20.6 mg/day at 15 weeks). Capillary fine deposits of IgG and C3 were seen by immunofluorescence, and subepithelial electron dense deposits (EDD) by transmission electron microscopy (TEM). Using the tissue-negative staining method, regular meshwork structure consisted of fine fibrils and pores (2.5 +/- 0.7 nm in short dimension) was observed in the GBM of control rats. At 10 and 15 weeks after injection, the GBM, directly facing the endothelial side of EDD, contained enlarged pores and nephrotic tunnels. Mean values of the short dimension of enlarged pores were 2.9 +/- 0.5 nm at 10 weeks and 3.1 +/- 0.4 nm at 15 weeks, which were significantly larger than that of control rats (p < 0.01). The rest area of the GBM, including newly produced GBM covering the epithelial side of EDD, had no significant difference in size of the pores from control GBM and no tunnels. Although there was no significant difference in the size of enlarged pores between 10 and 15 weeks, the percentage area of GBM with impaired size barrier increased at 15 weeks (51.4 +/- 8.1%) compared with 10 weeks (24.0 +/- 8.3%) and related to severity of proteinuria. The density of the tunnels also increased at 15 weeks. In conclusion, immune deposits may affect the GBM biosynthesis and induce the defect of size barrier of the GBM, which is responsible for proteinuria in active Heymann nephritis.
Insights
New staining methods reveal that immune deposits in Heymann nephritis enlarge glomerular basement membrane pores. This defect in the GBM
Area of Science:
- Nephrology
- Immunopathology
- Structural Biology
Background:
- Membranous nephropathy is a leading cause of nephrotic syndrome in adults.
- Active Heymann nephritis is a rat model mimicking human membranous nephropathy.
- The glomerular basement membrane (GBM) structure and its role in proteinuria are not fully understood.
Purpose of the Study:
- To investigate the ultrastructural alterations of the GBM in active Heymann nephritis.
- To clarify the mechanism of proteinuria in this model using a novel tissue-negative staining method.
Main Methods:
- Active Heymann nephritis induced in Lewis rats via proximal tubular brush border antigen (Fx1A) injection.
- Tissue-negative staining method to visualize GBM ultrastructure.
- Urinary protein excretion measurement, immunofluorescence, and transmission electron microscopy (TEM).
Main Results:
- Proteinuria developed progressively, correlating with GBM alterations.
- GBM pores enlarged significantly (2.9-3.1 nm) in areas facing immune deposits.
- Increased GBM area with impaired size barrier (up to 51.4%) and tunnels observed over time.
Conclusions:
- Immune deposits in Heymann nephritis may disrupt GBM biosynthesis.
- Enlarged GBM pores and tunnels create defects in the size barrier.
- These GBM structural defects are likely responsible for proteinuria in active Heymann nephritis.